BONE MARROW DEPRESSION AFTER DRUG THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
D000293:Adolescent; D000380:Agranulocytosis; D000740:Anemia; D000741:Anemia, Aplastic; D000900:Anti-Bacterial Agents; D001853:Bone Marrow; D001855:Bone Marrow Diseases; D003061:Codeine; D003863:Depression; D011431:Dextropropoxyphene; D004342:Drug Hypersensitivity; D004358:Drug Therapy; D006886:Hydroxychloroquine; D008180:Lupus Erythematosus, Systemic; D008709:Methenamine; D011239:Prednisolone / Q000627:therapeutic use*; D012459:Salicylates; D013449:Sulfonamides; D014116:Toxicology
D000900:Anti-Bacterial Agents; D012459:Salicylates; D013449:Sulfonamides; D006886:Hydroxychloroquine; D011239:Prednisolone; D008709:Methenamine; D011431:Dextropropoxyphene; D003061:Codeine
ADOLESCENCE; AGRANULOCYTOSIS; ANEMIA, APLASTIC; ANTIBIOTICS; BONE MARROW DISEASES; CODEINE; DRUG HYPERSENSITIVITY; DRUG THERAPY; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; METHENAMINE; PREDNISOLONE, THERAPEUTIC; PROPOXYPHENE; SALICYLATES; SULFONAMIDES; TOXICOLOGIC REPORT